Tag: speed and agility

Advanced Analytics | Analytics
Jen Dunham 0
3 ways NCDOT is transforming transportation through data and analytics

With dynamically changing revenue streams, critical infrastructure needs and current higher-than-average gas prices and inflation concerns, transportation agencies around the country are using data to enable analytically driven decisions while navigating complex business challenges. Today's transportation industry is ripe with opportunities for innovation and growth. And this is especially true

Analytics | Cloud | SAS Events
Shadi Shahin 0
Your analytics, your way

Maybe you’re a SAS®9 programmer in the insurance industry who stores her analytics projects in a local desktop folder, or in a Git library. Or maybe you’re a data scientist who specializes in aviation forecasting and loves the no-code environment of SAS® Viya®. Or maybe you’re a Python devotee at

Advanced Analytics | Analytics | Artificial Intelligence | Cloud | Data Management | Data Visualization | Machine Learning
Charlie Chase 0
How life science and health care supply chains can adapt to disruption

Robert Handfield, PhD, is a distinguished professor of Supply Chain Management at North Carolina State University and Director of the Supply Chain Resource Cooperative. In an episode of the Health Pulse Podcast, Handfield gave his views regarding the challenges health care and life science companies have encountered over the past two years

Analytics
Pippa White 0
Life sciences: now is the time to embrace analytics in the cloud

Research, supply chain, manufacturing, and sales increasingly depend on partnerships in a digital ecosystem. Cloud-based analytics makes it possible to collaborate intelligently at scale. For years, life sciences companies have been justifiably cautious about moving their data science functions into the cloud. Although the industry’s central purpose is to accelerate

Advanced Analytics | Analytics
Soundarya Palanisamy 0
Decentralizing clinical trials: how COVID-19 has changed drug development

The COVID-19 pandemic brought an enormous urgency to the life sciences sector. Companies vied for suitable treatments and in less than a year, COVID-19 vaccines were developed. This demonstrated clearly that the sector could move at speed when necessary. Though vaccines were supported by regulators, inefficiencies in vaccine and drug development were exposed.